Tufts Center Director Kaitin Discusses Pharmacogenomics Future | GenomeWeb

At A Glance

Name: Kenneth Kaitin

Position: Director of the Tufts Center for the Study of Drug Development

Background: Following a postgraduate “stint” at Stanford University, Kaitin joined Tufts, where he has remained for the past 17 years.

Age: 49


If you’ve heard of the Tufts Center for the Study of Drug Development you know its famous pronouncement that it costs $800 million for a drug to win regulatory approval in the United States.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.